Literature DB >> 29058071

[Volumetric analysis of vascularized pigment epithelium detachment in AMD: post hoc analysis of the RECOVER study].

C R Clemens1, F Alten2, P Heiduschka2, M A Gamulescu3, A Wolf4, N Eter2.   

Abstract

BACKGROUND: The ratio of choroidal neovascularization (CNV) and pigment epithelium detachment (PED) represents an important parameter regarding the risk of developing a tear of the retinal pigment epithelium (RPE) in patients with vascularized PED due to age-related macular degeneration (AMD).
METHODS: Within the framework of the RECOVER study a total of 29 treatment-naive patients with vascularized PED underwent fluorescein angiography (FA), indocyanine green angiography (ICGA) and optical coherence tomography (OCT) volume scans. The CNV-PED ratio was evaluated retrospectively by two independent graders in three ways: 1) manually based on the en face image of the FA late phase and 2) manually based on the en face image of the ICGA late phase. 3) In every OCT scan encompassing the PED, the area between the RPE and Bruch's membrane and the CNV area was measured and multiplied by the distance between OCT scans in order to determine volumetric data of CNV, PED and the serous cavity.
RESULTS: The FA and ICGA showed a mean serous area of 6.14 ± 4.21 mm2 (ICGA 5.94 ± 4.13 mm2), a mean CNV area of 3.25 ± 1.79 mm2 (ICGA 2.84 ± 1.68 mm2) and a mean PED area of 9.39 ± 4.27 mm2 (ICGA 8.79 ± 4.23 mm2) resulting in a mean two-dimensional morphological ratio of 0.35 ± 0.21 (ICGA 0.32 ± 0.22). The volumetric measurement revealed a mean CNV volume of 0.63 ± 0.67 mm3, a mean serous volume of 3.61 ± 3.83 mm3 and a mean total PED volume of 4.25 ± 3.68 mm3. The mean three-dimensional morphological ratio was 0.15 ± 0.29. The difference between the two-dimensional ratios of FA (p < 0.0001) and ICGA (p = 0.0004) was significant compared to the three-dimensional OCT ratio.
CONCLUSION: Assessment of the CNV-PED ratio using volumetric OCT measurements is an additional tool to the en face modalities FA and ICGA. This seems to be clinically relevant regarding the risk stratification of RPE tear development in PED patients and for the planning of the treatment regimen.

Entities:  

Keywords:  Age-related macular degeneration; Anti-VEGF; Fluorescein angiography; Optical coherence tomography; Retinal pigment epithelial tear

Mesh:

Substances:

Year:  2018        PMID: 29058071     DOI: 10.1007/s00347-017-0586-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  16 in total

1.  Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications.

Authors:  D Pauleikhoff; D Löffert; G Spital; M Radermacher; J Dohrmann; A Lommatzsch; A C Bird
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-06-25       Impact factor: 3.117

2.  High-resolution optical coherence tomography of subpigment epithelial structures in patients with pigment epithelium detachment secondary to age-related macular degeneration.

Authors:  Christoph R Clemens; Tim U Krohne; Peter Charbel Issa; Hans-Martin Helb; Nina Kosanetzky; Albrecht Lommatzsch; Frank G Holz; Nicole Eter
Journal:  Br J Ophthalmol       Date:  2012-06-13       Impact factor: 4.638

Review 3.  Retinal Pigment Epithelium Tears: Risk Factors, Mechanism and Therapeutic Monitoring.

Authors:  Christoph R Clemens; Nicole Eter
Journal:  Ophthalmologica       Date:  2015-10-22       Impact factor: 3.250

4.  Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration.

Authors:  Sibel Doguizi; Sengul Ozdek
Journal:  Retina       Date:  2014-06       Impact factor: 4.256

Review 5.  Retinal pigment epithelial detachments in the elderly.

Authors:  A C Bird; J Marshall
Journal:  Trans Ophthalmol Soc U K       Date:  1986

6.  Quantitative imaging of retinal pigment epithelial detachments using spectral-domain optical coherence tomography.

Authors:  Fernando M Penha; Philip J Rosenfeld; Giovanni Gregori; Manuel Falcão; Zohar Yehoshua; Fenghua Wang; William J Feuer
Journal:  Am J Ophthalmol       Date:  2011-10-25       Impact factor: 5.258

7.  Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.

Authors:  Brandon G Busbee; Allen C Ho; David M Brown; Jeffrey S Heier; Ivan J Suñer; Zhengrong Li; Roman G Rubio; Phillip Lai
Journal:  Ophthalmology       Date:  2013-01-23       Impact factor: 12.079

8.  Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.

Authors:  Clement K Chan; Carsten H Meyer; Jeffrey G Gross; Prema Abraham; Asha S D Nuthi; Gregg T Kokame; Steven G Lin; Michael E Rauser; Peter K Kaiser
Journal:  Retina       Date:  2007-06       Impact factor: 4.256

9.  Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-04

10.  Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

Authors:  Jeffrey S Heier; David M Brown; Victor Chong; Jean-Francois Korobelnik; Peter K Kaiser; Quan Dong Nguyen; Bernd Kirchhof; Allen Ho; Yuichiro Ogura; George D Yancopoulos; Neil Stahl; Robert Vitti; Alyson J Berliner; Yuhwen Soo; Majid Anderesi; Georg Groetzbach; Bernd Sommerauer; Rupert Sandbrink; Christian Simader; Ursula Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2012-10-17       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.